Associate professor in the Division of Pain Medicine, Department of Anesthesiology and Critical Care Medicine at the Johns Hopkins University School of Medicine in Baltimore, Maryland.
AMA J Ethics. 2020 Aug 1;22(1):E681-686. doi: 10.1001/amajethics.2020.681.
Marketing drugs and devices to clinicians affects their prescribing behaviors, drives up health care costs, and increases risk of harm to patients. This article canvasses what clinicians and health professions students should know about undue influence of drug and device marketing on their practices. It also considers policy changes that would better protect patients and better situate clinicians to care for patients and communities in ways that are ethical, safe, and effective.
向临床医生推销药品和医疗器械会影响他们的处方行为,推高医疗保健成本,并增加患者受到伤害的风险。本文概述了临床医生和卫生专业学生应该了解的药品和医疗器械营销对其实践的不当影响。它还考虑了政策的改变,这些改变将更好地保护患者,并更好地使临床医生以合乎道德、安全和有效的方式照顾患者和社区。